↓ Skip to main content

Autoimmune diseases and hypersensitivities improve the prognosis in ER-negative breast cancer

Overview of attention for article published in SpringerPlus, July 2013
Altmetric Badge

Mentioned by

googleplus
1 Google+ user

Citations

dimensions_citation
4 Dimensions

Readers on

mendeley
7 Mendeley
Title
Autoimmune diseases and hypersensitivities improve the prognosis in ER-negative breast cancer
Published in
SpringerPlus, July 2013
DOI 10.1186/2193-1801-2-357
Pubmed ID
Authors

Rickard Einefors, Ulrika Kogler, Carolina Ellberg, Håkan Olsson

Abstract

Breast cancer (BC) is one of the leading causes of death among women worldwide. Immunostimulatory treatment has increasingly been used as adjuvant therapy in the last few years, in patients with melanoma and other cancer forms, often with an induction of autoimmunity as a consequence of a successful treatment. We aimed at investigating if coexisting autoimmune diseases (AD) or hypersensitivities (HS) similarly to the side effects of immunostimulatory treatment resulted in a better overall survival, compared to patients without these disorders.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 7 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 7 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 2 29%
Student > Postgraduate 2 29%
Student > Ph. D. Student 1 14%
Unknown 2 29%
Readers by discipline Count As %
Medicine and Dentistry 2 29%
Environmental Science 1 14%
Immunology and Microbiology 1 14%
Agricultural and Biological Sciences 1 14%
Unknown 2 29%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 August 2013.
All research outputs
#15,276,424
of 22,716,996 outputs
Outputs from SpringerPlus
#932
of 1,852 outputs
Outputs of similar age
#122,420
of 198,191 outputs
Outputs of similar age from SpringerPlus
#48
of 86 outputs
Altmetric has tracked 22,716,996 research outputs across all sources so far. This one is in the 22nd percentile – i.e., 22% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,852 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.7. This one is in the 35th percentile – i.e., 35% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 198,191 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 28th percentile – i.e., 28% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 86 others from the same source and published within six weeks on either side of this one. This one is in the 11th percentile – i.e., 11% of its contemporaries scored the same or lower than it.